Insights

Recent Acquisition The acquisition of Xpress Biologics by PolyPlus Battery Company indicates a strategic expansion into advanced biotherapeutic manufacturing and suggests potential collaboration opportunities in cell and gene therapy projects or plasmid DNA production for targeted clients.

Focused Services Xpress Biologics specializes in microbial expression systems for producing recombinant proteins, antibody fragments, and plasmid DNA, offering scalable solutions from research to preclinical grades, which aligns well with companies seeking flexible contract manufacturing for early-stage biopharmaceuticals.

Regulatory Readiness Their processes are designed to meet regulatory and industrial requirements, making it easier for potential clients to transfer projects to GMP-compliant manufacturing, presenting opportunities to target biotech firms preparing for clinical development and commercialization.

Growth Potential With a revenue range of up to $1 million and recent strategic acquisition, there is significant growth potential for partners interested in early-stage biologics development, particularly those focusing on microbial expression platforms and scalable bioproduction.

Market Entry Being a one-stop-shop for contract services—including antibody screening, development, and GMP production—positions Xpress Biologics as an ideal partner for biotech companies looking to streamline their early development and transition to clinical manufacturing without extensive outside vendor management.

Similar companies to Xpress Biologics

Xpress Biologics Tech Stack

Xpress Biologics uses 8 technology products and services including Open Graph, Drupal, Salesforce, and more. Explore Xpress Biologics's tech stack below.

  • Open Graph
    Content Management System
  • Drupal
    Content Management System
  • Salesforce
    Customer Relationship Management
  • Modernizr
    Javascript Libraries
  • OVHcloud
    Platform As A Service
  • PHP
    Programming Languages
  • Google Analytics
    Web Analytics
  • Adobe Fonts
    Web Fonts

Xpress Biologics's Email Address Formats

Xpress Biologics uses at least 1 format(s):
Xpress Biologics Email FormatsExamplePercentage
F.Last@xpress-biologics.comJ.Doe@xpress-biologics.com
50%
F.Last@xpress-biologics.comJ.Doe@xpress-biologics.com
50%

Frequently Asked Questions

Where is Xpress Biologics's headquarters located?

Minus sign iconPlus sign icon
Xpress Biologics's main headquarters is located at 89 Avenue du Parc Industriel Milmort, Wallonia 4041 Belgium. The company has employees across 2 continents, including EuropeNorth America.

What is Xpress Biologics's official website and social media links?

Minus sign iconPlus sign icon
Xpress Biologics's official website is xpress-biologics.com and has social profiles on LinkedIn.

What is Xpress Biologics's SIC code NAICS code?

Minus sign iconPlus sign icon
Xpress Biologics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Xpress Biologics have currently?

Minus sign iconPlus sign icon
As of March 2026, Xpress Biologics has approximately 25 employees across 2 continents, including EuropeNorth America. Key team members include Usp Project Leader | Fermentation Advisor: R. L.Quality Control Manager: C. D.Project Leader: P. Z.. Explore Xpress Biologics's employee directory with LeadIQ.

What industry does Xpress Biologics belong to?

Minus sign iconPlus sign icon
Xpress Biologics operates in the Biotechnology Research industry.

What technology does Xpress Biologics use?

Minus sign iconPlus sign icon
Xpress Biologics's tech stack includes Open GraphDrupalSalesforceModernizrOVHcloudPHPGoogle AnalyticsAdobe Fonts.

What is Xpress Biologics's email format?

Minus sign iconPlus sign icon
Xpress Biologics's email format typically follows the pattern of F.Last@xpress-biologics.com. Find more Xpress Biologics email formats with LeadIQ.

When was Xpress Biologics founded?

Minus sign iconPlus sign icon
Xpress Biologics was founded in 2014.

Xpress Biologics

Biotechnology ResearchWallonia, Belgium11-50 Employees

Sartorius Xpress Biologics, is a biotech company proposing contract services for the production of recombinant proteins, antibody fragments and plasmid DNA for preclinical applications (therapeutic and diagnostic markets). The production scale goes from 100 mg up to 10 g with, depending of the use of the biologics, “R&D” and “GLP” qualities.  The production processes proposed by Xpress Biologics are all developed in microbial expression system, E. coli (soluble cytoplasmic, inclusion bodies and periplasmic productions) and P. pastoris (secreted protein) mainly.

These processes are IP free and take into account the regulatory and industrial (scale-up) requirements which facilitate the transfer of the project to CMOs (Contract Manufacturing Organizations) for the production of “GMP” grade material if necessary.

Xpress Biologics acts as One-Stop-Shop and can, through project management with defined subcontractors, take in charge additional services as the screening and development of antibodies against specific targets, the production of “GMP” grade material, the organization of pre-clinical and clinical studies.

We wanted to share that we will not be actively posting or engaging on this LinkedIn account. However, you can continue to stay updated and connect with us over https://www.linkedin.com/showcase/106511553

We appreciate all the conversations and connections we’ve built here and look forward to continuing them on our other page.

Thank you for your support, and we hope to see you there!

Section iconCompany Overview

Headquarters
89 Avenue du Parc Industriel Milmort, Wallonia 4041 Belgium
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2014
Employees
11-50

Section iconFunding & Financials

  • $1M

    Xpress Biologics's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $1M

    Xpress Biologics's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.